Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Icons
Spotlight Poster Icon
Spotlight Poster Icon
Spotlight Winner
Spotlight Winner

  • Friday, Aug 26th
    3:30 PM – 5:00 PM CEST
    Methods and Considerations for Hypothesis-free Signal Detection Studies Accommodating Various Types of Medications, Populations, and Regions
    Location: C1M1
    Presenting Author: Miyuki Hsing-Chun Hsieh – NCKU Institute of Clinical Pharmacy and Pharmaceutical Sciences
    Author: Edward Lai, PhD – National Cheng Kung University
    Author: Andrew Bate – GSK
    Author: Nicole Pratt, FISPE – University of South Australia
    Author: Nam-Kyong Choi, PhD – Ewha Womans University
    Author: Judith C. Maro, PhD – Harvard Pilgrim Health Care Institute
    Author: Darren Toh, DSc, FISPE – Harvard Pilgrim Health Care Institute
    Pharmacovigilance
  • Sunday, Aug 28th
    1:30 PM – 1:45 PM CEST
    Surveillance of Antidepressant Safety (SADS): Comparison of Signal Detection of Serious Medical Events Using Tree-based Scan Statistics and Repeated Cohort Studies
    Location: C1M5
    Presenting Author: Mia Aakjær – University of Copenhagen
    Co-Author: Murat Kulahci – Department of Applied Mathematics and Computer Science, Technical University of Denmark
    Co-Author: Marie Louise De Bruin – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG Utrecht, The Netherlands
    Co-Author: Abdul Rauf Khan – Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen
    Co-Author: Morten Andersen, MD, PhD – University of Copenhagen
    Pharmacovigilance
  • Sunday, Aug 28th
    1:30 PM – 3:00 PM CEST
    Novel Approaches to Pharmacovigilance
    Location: C1M5
    Moderator: Nabarun Dasgupta – UNC Gillings School of Global Public Health
    Moderator: Jessica Paulus, ScD – OM1
    Pharmacovigilance
  • Sunday, Aug 28th
    1:45 PM – 2:00 PM CEST
    Myocarditis and Pericarditis Associated with SARS-CoV-2 Vaccines in Four European Countries Using Large Electronic Health Care Data Sources: A Population-based Descriptive Cohort and a Nested Self-controlled Risk Interval Study
    Location: C1M5
    Presenting Author: Judit Riera Arnau, Dr – University Medical Center Utrecht
    Co-Author: Sophie H. Bots – Utrecht University
    Co-Author: Anna Schultze – London School of Hygiene and Tropical Medicine
    Co-Author: Davide Messina – Agenzia Regionale di Sanita’, Florence Toscana, Italy
    Co-Author: Svetlana Belitser – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
    Co-Author: Carlos Duran – Julius Center for Health Sciences and Primary Care, Department of Data Science & Biostatistics, University Medical Center Utrecht, the Netherlands
    Co-Author: Ema Alsina – Department of Datascience & Biostatistics, Julius Center for Health Sciences and Primary Health. University Medical Center Utrecht, The Netherlands
    Co-Author: Ian Douglas, PhD – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
    Co-Author: Patricia García-Poza – AEMPS (Spanish Agency of Medicines and Medical Devices)
    Co-Author: Rosa Gini, PhD – Agenzia Reg Della Sanit
    Co-Author: Ron Herings, PharmD, PhD, FISPE – PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands
    Co-Author: Consuelo Huerta – Faculty of Medicine. Department of Public Health. Complutense University of Madrid
    Co-Author: Mar Martin-Perez – AEMPS
    Co-Author: Ivonne Martin – Department of Datascience & Biostatistics, Julius Center for Health Sciences and Primary Health. University Medical Center Utrecht, The Netherlands
    Co-Author: Jetty Overbeek – PHARMO Institute
    Co-Author: Olga Paoletti – ARS Toscana, Florence, Italy
    Co-Author: Patrick Souverein – Utrecht University
    Co-Author: Karin Swart – PHARMO Institute
    Co-Author: Olaf H. Klungel, PharmD, PhD, FISPE – University of Utrecht
    Co-Author: Miriam C. Sturkenboom, PharmD, PhD, FISPE – University Medical Center Utrecht
    Pharmacovigilance
  • Sunday, Aug 28th
    2:00 PM – 2:15 PM CEST
    Screening for Statin-related Prescribing Cascades Using High-throughput Sequence Symmetry Analysis
    Location: C1M5
    Presenting Author: Scott M. Vouri, PharmD, PharmD, PhD, PhD – University of Florida College of Pharmacy
    Co-Author: Earl J. Morris, IV, PharmD, MPH – University of Florida - Department of Pharmaceutical Outcomes & Policy
    Co-Author: Marta Walsh – University of Florida College of Pharmacy
    Co-Author: Leonie Hochleitner – University of Florida College of Pharmacy
    Co-Author: Matthew Muschett – University of Florida College of Pharmacy
    Co-Author: Jessica Agalliu – University of Florida College of Pharmacy
    Co-Author: Alyssa Dempsey – University of Florida College of Pharmacy
    Co-Author: Stephan Schmidt, PhD – Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA
    Co-Author: Carl Pepine – University of Florida College of Medicine
    Co-Author: Steven Smith – 2. Department of Pharmacotherapy & Translational Research, University of Florida College of Pharmacy, Gainesville, Florida, United States
    Pharmacovigilance
  • Sunday, Aug 28th
    2:15 PM – 2:30 PM CEST
    Detecting Adverse Drug Events in Dermatology Through Natural Language Processing of Physician Notes
    Location: C1M5
    Presenting Author: Lawrence Rasouliyan – OMNY Health
    Co-Author: Vikas Kumar – OMNY Health
    Co-Author: Veysel Kocaman, MSc – John Snow Labs
    Co-Author: David Talby, PhD – John Snow Labs
    Pharmacovigilance
  • Sunday, Aug 28th
    2:30 PM – 2:45 PM CEST
    Preliminary Results from HERO-together: A Post-emergency Use Authorization Observational Cohort Study to Evaluate the Safety of the Pfizer-BioNTech COVID-19 Vaccine in US Healthcare Workers and Community Members
    Location: C1M5
    Presenting Author: Emily OBrien – Duke Clinical Research Institute
    Co-Author: Cherise Wong, PhD – Pfizer, Inc
    Co-Author: Jack Shostak, PhD – Duke Clinical Research Institute
    Co-Author: Laura Webb – Duke Clinical Research Institute
    Co-Author: Lauren Cohen, MA, PMP – Duke Clinical Research Institute
    Co-Author: Heather Rubino, PhD – Pfizer, Inc
    Co-Author: Patrick Caubel, MD – Pfizer, Inc
    Co-Author: Amy Abernethy – Verily Life Sciences
    Co-Author: Adrian Hernandez, MD, MHS – Duke Clinical Research Institute
    Pharmacovigilance
  • Sunday, Aug 28th
    2:45 PM – 3:00 PM CEST
    Use of Anxiolytic, Hypnotic and Antidepressant Drugs After Dispensation of a Levonorgestrel 52 mg Intra-uterine System Compared to a 19.5 mg Intra-uterine System: A Nationwide Matched-cohort Study
    Location: C1M5
    Presenting Author: Noemie Roland, MPH, MD – French National Agency for Medicines and Health Products Safety
    Co-Author: Bérangère Baricault – Epiphare
    Co-Author: Jeremie Botton – French National Agency for Medicines and Health Products Safety
    Co-Author: Lise Duranteau – Gynaecology Unit and Reference Center for Rare Diseases of Genital Development, AP-HP, University Paris Saclay, Bicêtre Hospital, Le Kremlin-Bicêtre, France
    Co-Author: Rosemary Dray-Spira – EPI-PHARE
    Co-Author: Alain Weill – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France
    Co-Author: Mahmoud Zureik – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France
    Pharmacovigilance